Real-time enrollment status for this recurrent b-cell non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 1:30 AM UTC
| NCT Number | NCT07609030 |
| Recruiting Status | Recruiting |
| Condition | Recurrent B-Cell Non-Hodgkin Lymphoma |
| Phase | NA |
| Target Enrollment | 90 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Last Updated on CT.gov | May 27, 2026 (May 27, 2026) |
As of July 21, 2026: Clinical trial NCT07609030 is currently recruiting participants. This na study for recurrent b-cell non-hodgkin lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Ohio State University Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07609030 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07609030 was last updated May 27, 2026 (May 27, 2026). HelloStudys verifies this status automatically.